Global Peripheral Intravenous (IV) Catheter Market Segmentation, By Product Type (Short Peripheral IV Catheters, Integrated/Closed PIVC), Technology (Conventional PIVC, Safety PIVC), Applications (Oncology, Gastroenterology, Renal Diseases, Pediatric Diseases, Infectious Diseases and Others), End User (Hospitals, Ambulatory Surgical Centers, Clinics, Home Use, Others) – Industry Trends and Forecast to 2031.
Peripheral Intravenous (IV) Catheter Market Analysis
Over the last three decades, the diseases such as the cardiovascular, urological, and neurological disorders have surpassed cancer as the leading cause of death and morbidity worldwide. According to Department of Health figures from 2015, more than 40 percent of New York adults have a chronic ailment, and chronic diseases account for 23 percent of all hospitalizations in the state. Consequently, the market is expected to be driven by an increase in the use of peripheral intravenous catheters in the treatment of chronic disorders that lead to hospitalization within the forecasted period.
Peripheral Intravenous (IV) Catheter Market Size
Global peripheral intravenous (IV) catheter market size was valued at USD 1.86 billion in 2023 and is projected to reach USD 2.85 billion by 2031, with a CAGR of 5.5% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Peripheral Intravenous (IV) Catheter Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Key Market Players
|
BD (U.S.), B. Braun Melsungen AG (German), Smith Medical (U.S.), Terumo Corporation, Vygon (France), ICU Medical, Inc. (U.S.), VOGT Medical (Germany), RenovoRx, Inc., (U.S.), Retractable Technologies Inc. (U.S.), Nipro (Japan), MedSource Labs (U.S.), Argon Medical Devices, Inc.,(U.S.), Intra Special Catheters GmbH (Germany), Greiner Bio-One International GmbH (Austria), Medical Components, Inc., (U.S.), Ares Medikal (Turkey), ACE MEDICAL COMPANY (U.S.),, Merit Medical Systems, (U.S.), Heka s.r.l, (Italy), RAUMEDIC AG (Germany) and Teleflex Incorporated (U.S.)
|
|
Market Opportunities
|
|
Peripheral Intravenous (IV) Catheter Market Definition
A peripheral intravenous catheter (PIVC) is a thin flexible tube that is placed into a vein in the arm or leg to deliver medications and nutritional supplements. Blood samples are also collected for diagnostic purposes. Short peripheral intravenous catheters (PIVCs) and integrated/closed catheters are the two types of peripheral intravenous (IV) catheters (PIVCs).
Peripheral Intravenous (IV) Catheter Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Requirement Across Healthcare
The increase in prevalence of chronic diseases and rise in population aging are the most significant factors driving the growth for this market. The rise in number of hospitalizations is also expected to accelerate the market's overall growth.
Furthermore, the rise in focus on curtailing needle-stick injuries and high healthcare expenditure are also expected to fuel market growth. Moreover, the high adoption of safety ported short peripheral intravenous catheters also cushions the market’s growth within the forecasted period. The high adoption of these products in emerging economies is also projected to bolster the market's growth.
Opportunities
- Growing Technological Advancements
Moreover, the advancement in surgical and treatment technologies are estimated to generate lucrative opportunities for the market. Rise in awareness on advanced methods of treatment will further offer numerous growth opportunities for the market.
Restraints/Challenges Peripheral Intravenous (IV) Catheter Market
- High Costs and Other Complications
On the other hand, high cost of peripheral intravenous (IV) catheters is expected to curb the market growth. Moreover, the various complications associated with peripheral intravenous catheter are expected to obstruct the growth of the peripheral intravenous (IV) catheter market,
- Dearth of Professionals
Also, the shortage of skilled professionals or lack of training for the use of peripheral IV catheters are projected to challenge the peripheral intravenous (IV) catheter market in the forecast period of 2022-2029.
- Lack of Knowledge/ Awareness on Safe Usage
The inadequate information regarding the safe usage of peripheral intravenous (IV) catheter, further results in secondary infections due to needle stick injuries and HAIs leads to lower adoption of the peripheral intravenous catheters, which will hamper the growth. Moreover, the painful insertion associated with these catheters is estimated to hinder the market's overall growth.
This peripheral intravenous (IV) catheter market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the peripheral intravenous (IV) catheter market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Peripheral Intravenous (IV) Catheter Market
The peripheral intravenous (IV) catheter market was negatively impacted by the outbreak of COVID-19. COVID-19 pandemic posed significant difficulties to participants in the worldwide peripheral intravenous catheter market on a number of fronts
Various challenges emerged due to the imposition of the government's lockdown and social distancing restrictions to curb the COVID-19 pandemic outbreak. This further led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. The supply of raw materials necessary to produce peripheral intravenous catheters is difficult due to transportation facility inconsistencies. Furthermore, due to an increase in the number of patients suffering from COVID-19 and other life-threatening conditions, product distributors are experiencing erratic demand from retailers.
However, the market will witness a slight increment post COVID-19, as the manufacturers are focusing on various developments and innovations, market trends and other expansion strategies.
Peripheral Intravenous (IV) Catheter Market Scope
The peripheral intravenous (IV) catheter market is segmented on the basis of product type, technology, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Short Peripheral Intravenous Catheters
- Integrated/Closed PIVC
Technology
- Conventional PIVC
- Safety PIVC
Applications
- Oncology
- Gastroenterology
- Renal Diseases
- Pediatric Diseases
- Infectious Diseases
- Others
End User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Home Use
- Others
Peripheral Intravenous (IV) Catheter Market Regional Analysis
The peripheral intravenous (IV) catheter market is analyzed and market size insights and trends are provided by country, product type, technology, applications and end user as referenced above.
The countries covered in the peripheral intravenous (IV) catheter market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the peripheral intravenous (IV) catheter market because of the large pool of geriatric population, well-developed healthcare infrastructure, high healthcare spending, and advancement in technology within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in disposable income, improving healthcare infrastructure and high growth in medical tourism industry within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Peripheral Intravenous (IV) Catheter Market Share
The peripheral intravenous (IV) catheter market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to peripheral intravenous (IV) catheter market.
Peripheral Intravenous (IV) Catheter Market Leaders Operating in the Market Are:
- BD (U.S.)
- B. Braun Melsungen AG (German)
- Smith Medical (U.S.)
- Terumo Corporation (Japan)
- Vygon (France)
- ICU Medical, Inc (U.S.)
- VOGT Medical (Germany)
- RenovoRx, Inc (U.S.)
- Retractable Technologies Inc (U.S.)
- Nipro (Japan)
- MedSource Labs (U.S.)
- Argon Medical Devices, Inc (U.S.)
- Intra Special Catheters GmbH (Germany)
- Greiner Bio-One International GmbH (Austria)
- Medical Components, Inc (U.S.)
- Ares Medikal (Turkey)
- ACE MEDICAL COMPANY (U.S.),
- Merit Medical Systems (U.S.)
- Heka s.r.l, (Italy)
- RAUMEDIC AG (Germany)
- Teleflex Incorporated (U.S.)
SKU-